Lifeboat Foundation

The U.S. Surgeon General has released an advisory alerting the public at large that loneliness has become an epidemic and represents an urgent public health concern. You might be tempted to think that this advisory is somewhat over the top and that loneliness is merely something that we all need to contend with from time to time. It seems obvious that loneliness happens. It seems obvious that loneliness is challenging.

Why should the nation’s highest official public health advisor make such a seemingly outsized clamor over a matter that we take for granted and assume is a natural part of living our lives?

Artificial intelligence-powered BacterAI accurately predicts the necessary amino acid combinations for growth 90% of the time.

A group of scientists has created a system powered by artificial intelligence (AI) that enables robots to conduct as many as 10,000 scientific experiments independently in a single day.

The AI system, named BacterAI, could significantly accelerate the pace of discovery in a range of fields such as medicine, agriculture, and environmental science. In a recent research study released in Nature Microbiology, the team successfully utilized BacterAI to map the metabolic processes of two microbes linked with oral health.

Stinging of Hymenoptera can induce IgE-mediated hypersensitivity reactions in patients with venom allergies, ranging from local to severe systemic reactions and even fatal anaphylaxis. Allergic patients’ quality of life can be primarily improved by injecting increased venom doses to alter their immune response to tolerate venom. This venom-specific immunotherapy is very effective and well tolerated, especially in the administration of vaccines. Creative Biolabs is a world leader in the field of vaccine development. With our extensive experience and advanced platform, we are therefore confident in offering the best vaccine development services for allergic disease.

Creative Biolabs provides vaccine development services for bee venom allergy according to customer’s detailed requirements.

Exercise decreases the risk of cancer and reduces side effects of cancer treatments. In addition, it improves patients’ quality of life and the prognosis of cancer patients. This is according to two new Finnish studies.

“It was previously thought that cancer patients should just rest after a cancer diagnosis. Today, we have more and more researched information that exercise can even improve the prognosis of cancer. However, it is not yet fully known how exercise controls cancer,” explains Research Assistant Tiia Koivula.

Previous preclinical studies have found that exercise affects the functioning of the immune system so that more immune cells are transferred to the tumor site and they become more active in destroying cancer cells. Two studies conducted at the Turku PET Center of the University of Turku in Finland aimed to find out whether a short exercise bout affects the mobilization of immune cells in cancer patients.

Some of the big AI tech companies (Google, Microsoft, OpenAI, and Anthropic) sat with Vice-President Kamala Harris for two hours on Thursday. President Biden stopped by the meeting, telling the execs “What you’re doing has enormous potential and enormous danger.” An “independent exercise” at DEF CON 31, a major hacker event in August, will provide a transparent public assessments of how well existing generative AI systems meet the Biden administration’s AI Bill of Rights blueprint.

Is it possible to get ahead of unintended consequences?

Accelerating Breakthroughs in Critical and Emerging Technologies — Dr. Erwin Gianchandani, Ph.D. — Assistant Director for Technology, Innovation and Partnerships, U.S. National Science Foundation (NSF)

Dr. Erwin Gianchandani, Ph.D. is Assistant Director for Technology, Innovation and Partnerships, U.S. National Science Foundation, leading the newly established TIP Directorate (https://new.nsf.gov/tip/leadership).

Continue reading “Dr Erwin Gianchandani — Assistant Director for Technology, Innovation and Partnerships, U.S. NSF” »

Engineering organs to replace damaged hearts or kidneys in the human body may seem like something out of a sci-fi movie, but the building blocks for this technology are already in place. In the burgeoning field of tissue engineering, live cells grow in artificial scaffolds to form biological tissue. But to evaluate how successfully the cells develop into tissue, researchers need a reliable method to monitor the cells as they move and multiply.

Now, scientists at the National Institute of Standards and Technology (NIST), the U.S Food and Drug Administration (FDA) and the National Institutes of Health (NIH) have developed a noninvasive method to count the live cells in a three-dimensional (3D) scaffold. The real-time technique images millimeter-scale regions to assess the viability of the cells and how the cells are distributed within the scaffold—an important capability for researchers who manufacture complex biological tissues from simple materials such as living cells.

Their findings have been published in the Journal of Biomedical Materials Research Part A.

An artificial intelligence system enables robots to conduct autonomous scientific experiments—as many as 10,000 per day—potentially driving a drastic leap forward in the pace of discovery in areas from medicine to agriculture to environmental science.

Reported today in Nature Microbiology, the research was led by a professor now at the University of Michigan.

Continue reading “AI could run a million microbial experiments per year, says study” »

Researchers at the Department of Psychiatry and Psychology, Center for Behavioral Health, Neurological Institute at the Cleveland Clinic in Ohio have authored a case report on the positive effects of psilocybin on color blindness.

Published in the journal Drug Science, Policy and Law, the researchers highlight some implications surrounding a single reported vision improvement self-study by a colleague and cite other previous reports, illustrating a need to understand better how these psychedelics could be used in therapeutic settings.

Past reports have indicated that people with color vision deficiency (CVD), usually referred to as color blindness, experience better color vision after using lysergic acid diethylamide (LSD) or psilocybin (magic mushrooms). There is a lack of scientific evidence for these claims, as researching the effects of these drugs has been highly restricted.